The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients

Angiology

Volumn 58, Issue 3, 2007, Pages 309-315

  Poredoš, Pavel ^a   Jug, Borut ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; ANKLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BRACHIAL ARTERY; CEREBROVASCULAR DISORDERS; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 34250758640     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707302494     Document Type: Article

References (24)

1. Jelnes R., Gaardsting O., Hougaard Jensen K: Fate in intermittent claudication: Outcome and risk factors. BMJ 293: 1137-1140, 1986.
2. Criqui M., Langer R., Fronek A.,, et al. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs 42: 16-21, 1991.
3. Criqui M., Denenberg J.: The generalized nature of atherosclerosis: How peripheral arterial disease may predict adverse events from coronary arterty disease. Vasc Med 3: 241-245, 1998.
4. Hirsch AT, Criqui MH, Treat-Jacobson D.,, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286: 1317-1324, 2001.
5. Jonason T., Bergstrom R.: Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 221: 253-260, 1987.
6. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342: 145-153, 2000.
7. Östergen J., Sleight P., Dagenais G.,, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25: 17-24, 2004.
8. Blankenhorn D., Azen S., Crawford D.,, et al. Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation 83: 438-447, 1991.
9. Allan PL, Mowbray PI, Lee AJ,, et al. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: The Edinburgh Artery Study. Stroke 28: 348-353, 1997.
10. Hollander M., Hak A., Koustaal P.,, et al. Comparison between measures of atherosclerosis and risk of stroke: The Rotterdam Study. Stroke 34: 2367-2372, 2003.
11. Klop R., Eikelboom B., Taks A.: Screening of internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5: 41-45, 1991.
12. Murabito JM, D'Agostino RB, Silbershatz H.,, et al. Intermittent claudication: A risk profile from the Framingham heart study. Circulation 96: 44-49, 1997.
13. Chambless LE, Folsom AR, Davis V.,, et al. Risk factors for progression of common carotid atherosclerosis: The atherosclerosis risk in communities study, 1987-1998. Am J Epidemiol 155: 38-47, 2002.
14. Smith SC Jr, Milani RV, Arnett DK,, et al. Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors. Circulation 109: 2613-2616, 2004.
15. Newman AB, Naydeck BL, Sutton-Tyrrell K.,, et al. Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults. Arterioscler Thromb Vasc Biol 22: 1674-1679, 2002.
16. Hooi J., Stoffers H., Kester A.,, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care 16: 177-182, 1998.
17. Kuller LH, Shemanski L., Psaty BM,, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 92: 720-726, 1995.
18. Psaty BM, Furberg CD, Kuller LH,, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The Cardiovascular Health Study. Arch Intern Med 159: 1339-1347, 1999.
19. Leng GC, Fowkes Fgr, Lee AJ,, et al. Use of ankle brachial pressure index to predict cardiovascular events and death: A cohort study. BMJ 313: 1440-1443, 1996.
20. Papamicael C., Lekakis J., Stamatelopoulos K.: Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 86: 615-618, 2000.
21. Karnegis J., Matts J., Tuna N.,, et al. Correlation of coronary with peripheral arterial stenosis. The POSCH Group. Atherosclerosis 92: 25-30, 1992.
22. Atmer B., Jogestrand T., Laska J.,, et al. Peripheral artery disease in patients with coronary artery disease. Int Angiol 14: 89-93, 1995.
23. Dieter R., Tomasson J., Gudjonsson T.,, et al. Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease. Vasc Med 8: 233-236, 2003.
24. Poredos P., Golob M., Jensterle M.: Interrelationship between peripheral arterial occlusive disease, carotid atherosclerosis and flow mediated dilation of the brachial artery. Int Angiol 22: 83-87, 2003.